Blood filtering for advanced pancreatic or colorectal cancer
Part of Cancer, Digestive system clinical trials.
This study tests a device that filters cancer cells from your blood. It may help slow down the cancer or improve how you feel, and it's for people with advanced pancreatic or colorectal cancer who have run out of standard treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have pancreatic or colorectal cancer that has spread, and standard chemotherapy either stopped working, caused bad side effects, or you can't take it.
- You must be willing to have a blood test to check for a certain number of cancer cells in your blood (at least 5 cells per small sample).
- You should be in reasonably good health and able to do most daily activities on your own.
- You must not be pregnant or breastfeeding, and if you could get pregnant, you must use effective birth control.
- You cannot have certain conditions like severe bleeding risk, uncontrolled infections, kidney failure needing dialysis, or a history of a specific blood-clotting problem (HIT).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a blood test that detects tumor DNA can help doctors decide early if the standard chemotherapy is working, and if switching treatment might be better. It is for people newly diagnosed with metastatic pancreatic cancer who are starting their first chemotherapy.
This study checks if a simple blood test can find tiny bits of cancer DNA after your pancreatic surgery, which may help detect if cancer comes back earlier than scans. By joining, you'll help doctors learn how to better monitor the disease and guide future treatments.
This study looks at blood and stool samples from people with advanced pancreatic cancer to understand how their body's metabolism and gut bacteria affect their disease and treatment. It aims to find better ways to predict and improve treatment outcomes.
This study looks at blood samples from people with early-stage pancreatic cancer to understand how the immune system behaves. The goal is to find better treatments. If you have pancreatic cancer that hasn't spread, they may ask you to donate blood for research.
This early-phase trial tests how well targeted medicines (and possibly an immunotherapy drug) work for people with pancreatic cancer that can’t be fully removed with surgery or has spread. It also looks at whether the treatment is safe and can shrink or control tumors by blocking specific cancer pathways.
This study is looking at genetic material and proteins from pancreatic tumors to understand how the cancer responds to treatment. It aims to help doctors choose the best therapies for patients with certain types of pancreatic cancer that can be removed surgically or that have not spread to other organs.
Hear when a new Pancreatic Ductal Adenocarcinoma (mPDAC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.